Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X5TB
|
||||
| Former ID |
DNC007945
|
||||
| Drug Name |
H-Cdp-ser-Gly-Phe-Leu-Thr-OH
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528724] | ||
| Formula |
C36H51N7O10
|
||||
| Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)NC(CO)C(=O)NCC(=O)NC(CC2=CC=CC=C2<br />)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)O)N)C)C(=O)N
|
||||
| InChI |
1S/C36H51N7O10/c1-18(2)11-26(35(51)43-30(21(5)45)36(52)53)41-34(50)27(14-22-9-7-6-8-10-22)40-29(46)16-39-33(49)28(17-44)42-32(48)25(37)15-24-19(3)12-23(31(38)47)13-20(24)4/h6-10,12-13,18,21,25-28,30,44-45H,11,14-17,37H2,1-5H3,(H2,38,47)(H,39,49)(H,40,46)(H,41,50)(H,42,48)(H,43,51)(H,52,53)/t21-,25+,26+,27+,28+,30+/m1/s1
|
||||
| InChIKey |
OCIDAPABHMBEIS-VVPQYXBXSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Delta-type opioid receptor | Target Info | Inhibitor | [528724] | |
| Mu-type opioid receptor | Target Info | Inhibitor | [528724] | ||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
| Enkephalin release | |||||
| Opioid proenkephalin pathway | |||||
| Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||